FDM Group (Holdings) plc (LON:FDM)

Revance Therapeutics Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	15.5	20.51	40.77	34.91	31.83	30.78
Depreciation & Amortization	5.41	5.41	5.74	6.2	6.06	6.4
Other Amortization	-	-	-	0.22	0.1	0.1
Loss (Gain) From Sale of Assets	-0.17	-0.17	0.16	0.13	0	0.02
Stock-Based Compensation	1.2	1.2	-5.34	6.73	5.62	2.19
Other Operating Activities	5.85	3.06	2.92	-2.31	-0.36	-0.4
Change in Accounts Receivable	3.86	3.86	11.39	-11.33	-5.12	9.8
Change in Accounts Payable	-4.64	-4.64	-5.47	1.87	3.47	5.89
Operating Cash Flow	27.02	29.24	50.15	36.42	41.6	54.77
Operating Cash Flow Growth	-40.17%	-41.70%	37.72%	-12.46%	-24.05%	16.91%
Capital Expenditures	-0.34	-0.34	-0.65	-1.2	-0.37	-0.54
Sale (Purchase) of Intangibles	-	-	-	-	-	-0.08
Investing Cash Flow	-0.34	-0.34	-0.65	-1.2	-0.37	-0.62
Long-Term Debt Repaid	-	-3.68	-4.81	-5.47	-5.29	-5.29
Net Debt Issued (Repaid)	-3.32	-3.68	-4.81	-5.47	-5.29	-5.29
Issuance of Common Stock	0.17	0.3	0.49	0.51	0.5	0.75
Repurchase of Common Stock	-	-	-2.53	-	-	-
Common Dividends Paid	-24.62	-31.68	-39.32	-38.15	-46.82	-20.09
Other Financing Activities	-1.39	-1.28	-0.79	-0.6	-0.65	-0.81
Financing Cash Flow	-29.16	-36.34	-46.95	-43.72	-52.26	-25.44
Foreign Exchange Rate Adjustments	0.16	0.79	-0.85	0.91	-0.57	-0.97
Net Cash Flow	-2.33	-6.64	1.7	-7.6	-11.61	27.75
Free Cash Flow	26.68	28.9	49.5	35.21	41.23	54.23
Free Cash Flow Growth	-40.76%	-41.61%	40.58%	-14.59%	-23.97%	22.88%
Free Cash Flow Margin	12.42%	11.22%	14.82%	10.67%	15.42%	20.26%
Free Cash Flow Per Share	-	0.26	0.45	0.32	0.37	0.50
Cash Interest Paid	1.33	1.23	0.72	0.47	0.56	0.75
Cash Income Tax Paid	4.49	5.8	12.74	13.67	10.61	11.46
Levered Free Cash Flow	25.44	27.04	39.55	27.98	35.25	48.43
Unlevered Free Cash Flow	26.29	27.83	40	28.27	35.61	48.9
Change in Working Capital	-0.77	-0.77	5.92	-9.46	-1.65	15.69

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.